Bluejay Diagnostics (NASDAQ:BJDX) Trading Up 0.5% – Time to Buy?

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) traded up 0.5% during mid-day trading on Monday . The stock traded as high as $1.91 and last traded at $1.87. 40,605 shares were traded during trading, a decline of 93% from the average session volume of 542,790 shares. The stock had previously closed at $1.86.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Bluejay Diagnostics in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Bluejay Diagnostics presently has a consensus rating of “Sell”.

Bluejay Diagnostics Stock Performance

The stock’s fifty day moving average price is $2.67 and its 200-day moving average price is $5.08. The firm has a market cap of $1.33 million, a PE ratio of 0.00 and a beta of 0.72.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Bluejay Diagnostics stock. Armistice Capital LLC purchased a new stake in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 65,000 shares of the company’s stock, valued at approximately $43,000. Armistice Capital LLC owned 9.15% of Bluejay Diagnostics at the end of the most recent quarter. 18.47% of the stock is owned by institutional investors and hedge funds.

About Bluejay Diagnostics

Bluejay Diagnostics, Inc (NASDAQ: BJDX) is a molecular diagnostics company focused on developing saliva-based tests for autoimmune and gastrointestinal conditions. The company’s lead diagnostic product is designed to detect tissue transglutaminase (tTG) antibodies in patient saliva samples, offering a noninvasive, point-of-care alternative to traditional blood draws and endoscopic procedures.

Leveraging a proprietary immunoassay platform, Bluejay’s technology aims to streamline the detection and monitoring of celiac disease by providing rapid results outside of a conventional laboratory setting.